The new innovations are yet to come We will see a lot of new technologies come out in the next 12 months or 18 months. Handling these trends means sticking to basics, Pingle said
GLP-1/GIP Receptor Agonists: The Good News Eli Lillys phase 3 trials for tirzepatide for glycemic control in adults with T1D and obesity or overweight (SURPASS-1-T1D and SURPASS-2-T1D) are fully enrolled, with results expected in the coming months
Inventory systems help you spot problems before theyre big enough to matter
Elution yields decreased for all columns below 3-min residence time due to losses to the GSH FT
Employee Coverage, Eligibility, and Participation Employers are the principal source of health insurance in the United States, providing health benefits for 154 million nonelderly people
Oil topped $100 a barrel for the first time since May after Yemen's Houthi rebels targeted Saudi ships in the Red Sea, threatening to cut off another route for oil exports already choked by the effective closure of the Strait of Hormuz
.webp?t=1743535811)
